Easter Holiday Notice: Orders placed between April 3-13 will be shipped from April 14. Thank you for your patience!
Next-generation peptides researched for metabolic pathways including appetite regulation, energy expenditure, and lipid metabolism. Retatrutide is the first triple-acting GIP/GLP-1/Glucagon agonist, AOD-9604 targets lipolysis via the GH pathway, and Cagrilintide acts through the amylin receptor.

€49.99
€55.49
2 variants

€149.99
€179.99
3 variants